The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.
Sepsis is a potentially fatal illness that arises when the body’s immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.
Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS10358
Market Trends and Drivers
Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10358
Global Sepsis Diagnostics Market Segmentation
Product
- Instruments
- Blood Culture Media
- Assay Kits and Reagents
Technology
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
Pathogen
- Bacterial Sepsis
- Fungal Sepsis
- Others
Testing Type
- Laboratory Testing
- PoC Testing
End-use
- Hospitals and specialty clinics
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes
Major Players in the Global Sepsis Diagnostics Market
The key players in the market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US) and Abbott Laboratories (US), among others.
Purchase This Market Research Report – https://www.globalinsightservices.com/checkout/single_user/GIS10358
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/